semaglutide cause gallstones GLP-1 Side Effects and Semaglutide: Why Smart Biomarker Monitoring Matters Ozempic Gallbladder Lawsuit Update |

Long-term use of brand-name medication can be costly

Access options Access through your institution Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Learn more Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Learn more Rent or buy this article Prices vary by article type from$1.95 to$39.95 Learn more Prices may be subject to local taxes which are calculated during checkout doi: Related Articles Blood tests for Alzheimers disease could reshape research and care The TREM2 agonistic antibody AL002 in early Alzheimers disease: a phase 2 randomized trial A minimally invasive dried blood spot biomarker test for the detection of Alzheimers disease pathology Read more research highlights selected by the Nature Medicine team Subjects Biomarkers Neurodegeneration Alzheimer's disease Latest on: Biomarkers Neurodegeneration An ECG biomarker for sudden cardiac death discovered with deep learning Article Passive heart-rate monitoring during smartphone use in everyday life Article Universal transcriptomic hallmarks of mammalian ageing and mortality Article Cell-type signatures of Alzheimers disease shared across population groups Article Dementia risk in middle-aged people linked to a blood protein Research Highlight The brain region that could provide a cognitive reservoir in old age Research Highlight Jobs Postdoctoral Researcher in Immunology and molecular biology - Fangwei Leng Lab Postdoctoral researcher with a PhD in immunology and molecular biology investigating molecular mechanisms of Treg development and function

1 Our study underscores the potential of GLP-1 RAs as an adjunct strategy for improving cancer-related outcomes among patients with breast cancer, although clinical trials are needed to inform effective therapeutic approaches and clinical decision making, Fuemmeler said

Dose-Response Efficacy and Safety of Semaglutide in Japanese Patients with Type 2 Diabetes: A Subgroup Analysis of the SUSTAIN Trials